IBBR is a University of Maryland joint research enterprise in biotechnology designed to generate innovative solutions with medical and public health applications. IBBR enhances collaboration among UMB, UMCP, and the National Institute of Standards and Technology (NIST) and uses a rich network of interrelationships with other federal laboratories, corporate partners, and state agencies to advance scientific innovations and create commercialization relationships in Maryland. IBBR is actively engaged in new vaccine and drug discovery programs. In a recent award, IBBR is part of a nationwide public-private consortium to revolutionize U.S. biopharmaceutical manufacturing. With an expected investment of $250 million, the consortium will train workers in the full supply chain of biopharma manufacturing, grow U.S. production, and more quickly bring safe drugs to market. To address worldwide challenges of food supply, IBBR is developing an Agricultural Biotechnology Development Center in coordination with KeyGene, a Dutch-based agricultural biotech company and the leading ag-biotech company in Maryland.
IMPACT: This unique partnership with NIST fosters cross-disciplinary team approaches to scientific discovery and translational development. It is also focused on creating commercialization relationships and initiatives that serve the expanding economic base of biosciences and technology in the state of Maryland.Institute for Bioscience and Biotechnology Research
- Categories: Research